BIOMARKER:

KIT exon 11 mutation

B | Sensitive

C2 | Sensitive

C3 | Sensitive

C4 | Sensitive

B | Resistant

C2 | Resistant

C3 | Resistant

C4 | Resistant

Show legend

Drug categories

Tyrosine Kinase Inhibitors

Immunotherapy

Gastrointestinal Stromal Tumor

Melanoma

Gastric Cancer

imatinib

KIT exon 11 mutation|Gastrointestinal Stromal Tumor|imatinib

KIT exon 11 mutation|Melanoma|imatinib

KIT exon 11 mutation|Gastric Cancer|imatinib

ripretinib

KIT exon 11 mutation|Gastrointestinal Stromal Tumor|ripretinib

nilotinib

KIT exon 11 mutation|Gastrointestinal Stromal Tumor|nilotinib

KIT exon 11 mutation|Melanoma|nilotinib

sunitinib

KIT exon 11 mutation|Gastrointestinal Stromal Tumor|sunitinib

KIT exon 11 mutation|Melanoma|sunitinib

regorafenib

KIT exon 11 mutation|Gastrointestinal Stromal Tumor|regorafenib

ponatinib

KIT exon 11 mutation|Gastrointestinal Stromal Tumor|ponatinib

anlotinib

KIT exon 11 mutation|Gastrointestinal Stromal Tumor|anlotinib

avapritinib

KIT exon 11 mutation|Gastrointestinal Stromal Tumor|avapritinib

dasatinib

KIT exon 11 mutation|Melanoma|dasatinib